Skip to main content
. 2018 May 14;37(34):4692–4710. doi: 10.1038/s41388-018-0273-5

Fig. 2.

Fig. 2

KMT2C loss inhibits proliferation of ER+ cells. ad Breast cancer cells stably expressing either shRenilla or shKMT2C were assayed for proliferation using the alamarBlue cell viability assay. Values correspond to the mean of six experimental replicates ± s.e.m. All cells are cultured in full serum containing media e. Parental and MCF7 KMT2C CRISPR cells were assayed for proliferation using the alamarBlue cell viability assay. Values correspond to the mean of six experimental replicates ± s.e.m. Data correspond to one representative assay from a total of two or three independent assays. fi Indicated breast cancer cells stably expressing either shRenilla, shKMT2C or shKMT2D were assayed for proliferation using the alamarBlue cell viability assay. Values correspond to the mean of six experimental replicates ± s.e.m.